Company Filing History:
3 out of 44 
2 out of 52 
Years Active: 2011-2013
Title: The Innovative Contributions of Maj Hedtjarn
Introduction
Maj Hedtjarn is a prominent inventor based in Copenhagen, Denmark. She has made significant contributions to the field of medical research, particularly in the development of RNA antagonist compounds. With a total of three patents to her name, her work focuses on modulating gene expression to address various medical disorders, including cancer.
Latest Patents
Hedtjarn's latest patents include innovative compounds that target specific mRNA sequences. One of her notable inventions is related to RNA antagonist compounds for the modulation of PIK3CA expression. This invention involves oligomeric compounds that target PIK3CA mRNA in cells, leading to a reduction in PIK3CA expression. This reduction is beneficial for treating hyperproliferative diseases, such as cancer. The invention also provides therapeutic compositions that include these oligomers and methods for modulating PIK3CA expression.
Another significant patent focuses on RNA antagonist compounds for the modulation of HER3. This invention involves oligomer compounds that target HER3 mRNA, resulting in reduced expression of HER3, HER2, and EGFR. Similar to her work on PIK3CA, the reduction of these expressions is advantageous for treating various medical disorders, including hyperproliferative disorders like cancer. The invention offers therapeutic compositions comprising these oligomers and methods for modulating the expression of HER3, HER2, and EGFR.
Career Highlights
Throughout her career, Maj Hedtjarn has worked with notable companies in the pharmaceutical industry. She has been associated with Santaris Pharma A/S and Enzon Pharmaceuticals, Inc., where she has contributed her expertise in developing innovative therapeutic solutions.
Collaborations
[This section has been skipped due to space constraints.]
Conclusion
Maj Hedtjarn's innovative work in the field of RNA antagonist compounds showcases her dedication to advancing medical research and treatment options. Her contributions have the potential to significantly impact the treatment of various medical disorders, particularly cancer.